Skip to main content
LUMIBIRD logo

LUMIBIRD — Investor Relations & Filings

Ticker · LBIRD ISIN · FR0000038242 LEI · 969500MLJC3ZSZP4L019 PA Manufacturing
Open in API
Filings indexed 560 across all filing types
Latest filing 2021-01-05 Report Publication Anno…
Country FR France
Listing PA LBIRD

About LUMIBIRD

https://www.lumibird.com/en/

LUMIBIRD is a leading specialist in laser technologies with over 50 years of experience. The company designs and manufactures high-performance lasers based on its expertise in three key technologies: solid-state lasers, fiber lasers, and laser diodes. It operates through two primary divisions. The Photonics division provides advanced laser solutions for applications in defense, space, environmental monitoring (including Lidar sensors), industrial manufacturing, and scientific research. The Medical division offers innovative ophthalmological and medical solutions, ranging from diagnostic equipment to laser treatment systems, through brands such as Quantel Medical and Ellex.

Recent filings

Filing Released Lang Actions
Lumibird : CALENDRIER DE COMMUNICATION FINANCIERE
Report Publication Announcement Classification · 99% confidence The document is titled "CALENDRIER DE COMMUNICATION FINANCIERE" (Financial Communication Calendar) and lists future dates for various corporate events, including the release of annual results, Q1 results, the Annual General Meeting (Assemblée Générale Annuelle), and H1 results. The text explicitly states that the calendar is provided as an indication and may be subject to change. Crucially, it announces the upcoming publication of the 2020 annual revenue figures on 25/01/2021. Since the document itself is a schedule of future announcements rather than the detailed report (like a 10-K or IR) or the actual results release (ER), it fits best under the category for announcing the publication of reports. Given the short length (2436 chars) and the nature of announcing future report releases, the most appropriate classification is Report Publication Announcement (RPA).
2021-01-05 French
LUmibird: FINANCIAL COMMUNICATIONS AGENDA
Report Publication Announcement Classification · 99% confidence The document explicitly states it is the 'FINANCIAL COMMUNICATIONS AGENDA' for 2021, listing future disclosure dates for revenues, earnings, and the 'Annual Shareholders Meeting'. This is an announcement detailing the schedule of future corporate reports and events, not the reports themselves. Since it announces the schedule for various financial disclosures and corporate events, it fits best under Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. It is too specific to be a general Regulatory Filing (RNS).
2021-01-05 English
LUMIBIRD : Actions et droits de vote au 30 novembre 2020
Share Issue/Capital Change Classification · 95% confidence The document text is very short (772 characters) and presents a table detailing the 'Informations relatives au nombre total de droits de vote et d'actions' (Information relating to the total number of voting rights and shares) as required by French regulations (Code de commerce and AMF General Regulation). This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing. It is not a full report (10-K, IR), an earnings release (ER), or a management presentation (IP). While it is a regulatory filing, the specific nature of reporting total voting rights often falls under general regulatory announcements or specific capital structure updates. Given the options, it is a specific regulatory disclosure about the capital structure/voting rights. Since there isn't a perfect fit for 'Total Voting Rights Disclosure', I must evaluate the closest categories. It is not a Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Share Issue (SHA). It is a mandatory disclosure related to the company's capital structure and voting rights, which is often categorized under general regulatory filings or specific capital announcements. Because it is a formal, periodic disclosure mandated by financial authorities regarding the composition of capital and voting rights, it aligns best with a specific regulatory filing type. Given the provided definitions, 'Regulatory Filings' (RNS) is the most appropriate fallback for specific, non-standard regulatory disclosures that don't fit the other precise categories like DIRS or SHA, although it is highly specific. However, looking closely at the definitions, this disclosure is fundamentally about the capital structure and voting rights, which is a key component of corporate governance and capital reporting. Since it is a formal, periodic disclosure of capital structure metrics mandated by the regulator, and not a general announcement of a report (RPA), I will classify it as a specific regulatory filing. RNS is the best fit for mandatory, specific regulatory updates that lack a dedicated code here.
2020-12-08 French
LUMIBIRD BOUCLE 140 M€ DE FINANCEMENT BANCAIRE ET EURO PP POUR SOUTENIR SES AMBITIONS STRATEGIQUES
Capital/Financing Update Classification · 99% confidence The document text is a press release dated 02/12/2020 announcing that LUMIBIRD has secured €140 million in financing (a combination of bank loans and an Euro PP bond). The content focuses entirely on the details of this new debt/financing structure, its purpose (to support strategic ambitions and M&A), and the associated terms (including social impact covenants). This directly aligns with the definition of 'Capital/Financing Update'. The document length (4447 chars) is substantial enough to be the primary announcement itself, not just a notification of a report.
2020-12-02 French
Lumibird Secures €140m of Euro pp and Bank Financing to Support Its Strategic Ambitions
Capital/Financing Update Classification · 99% confidence The document is an announcement dated December 2, 2020, detailing that LUMIBIRD has secured €140M in financing through a combination of bank financing and a Euro PP social impact bond issue. The primary focus is on raising capital to support strategic ambitions, specifically doubling revenues by 2023 through organic and external growth. This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not an earnings release (ER), an interim report (IR), or a full annual report (10-K).
2020-12-02 English
LUMIBIRD : Actions et droits de vote au 31 octobre 2020
Share Issue/Capital Change Classification · 95% confidence The document is very short (800 characters) and presents a table detailing the 'total number of voting rights and shares' as required by French regulations (Code de commerce and AMF General Regulation). This type of mandatory disclosure, which reports on the total share capital and voting rights, is a specific regulatory filing. It does not fit the definitions for Annual Report (10-K), Earnings Release (ER), or Interim Report (IR). It is a specific regulatory disclosure related to share structure and voting power. Given the options, it is a specific regulatory announcement. Since there isn't a dedicated code for 'Voting Rights Disclosure' outside of DVA (which is for voting *results*), and it is a mandatory regulatory filing, it best fits under the general 'Regulatory Filings' (RNS) category, or potentially a specialized filing if one existed. However, based on the provided definitions, RNS is the most appropriate fallback for a specific, non-core financial/governance report that isn't covered elsewhere. It is not a declaration of voting results (DVA), but a statement of total rights.
2020-11-06 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.